Dexlansoprazole

Product overview

Dexlansoprazole Pellets – Dual Delayed-Release Multiparticulate Technology for PPI Formulations. Rraynex Dexlansoprazole Pellets are engineered for dual delayed-release pharmaceutical formulations requiring sequential release characteristics. The multiparticulate system uses controlled layering and enteric protection to support reproducible dissolution and extended acid-suppression formulations for pharmaceutical manufacturers. Overview: Dexlansoprazole is a proton pump inhibitor and the R-enantiomer of lansoprazole. Its DDR formulation is designed around two delayed-release phases. Rraynex applies controlled pelletization and coating processes to produce uniform multiparticulates suitable for capsule filling, sachets, and other dosage-form development programs. Key Features & Benefits: • Dual delayed-release pellet technology. • Controlled coating and dissolution characteristics. • Uniform pellet size and surface properties. • Suitable for capsule and multiparticulate formulations. • Technical support for development, scale-up, stability, and regulatory documentation. SEO Content: Rraynex manufactures Dexlansoprazole DDR Pellets, Dexlansoprazole Pellets, Dual Delayed Release Pellets, DDR Pellets, Proton Pump Inhibitor Pellets, PPI Pellets, Enteric Coated Pellets, Gastro Resistant Pellets, Delayed Release Pellets, MUPS Pellets, Capsule Filling Pellets, Pharmaceutical Pellets, Bulk Pharmaceutical Pellets, Dexlansoprazole Pellet Manufacturer, Dexlansoprazole Pellet Supplier, Dexlansoprazole Manufacturer India, Pharmaceutical Exporter, CDMO and Contract Manufacturing solutions.